Published DateClear

Start Date

End Date

Category

• Pipeline2

Organizations

• Bausch + Lomb66
• Eyes On Eyecare51
• Alcon, Inc.45
• American Optometric Association37
• Harrow29
• Glaukos27
• Topcon Healthcare25
• Regeneron23
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA2
• Rosah Syndrome2
• Clinical Trials2
• Retina1

• Organizations: Drug Farm✕

Clear all

Pipeline

FDA grants Fast Track designation for Drug Farm's ROSAH syndrome asset

S

Pipeline

Drug Farm receives FDA IND clearance for ROSAH syndrome candidate

ALPK1 selective kinase inhibitor is the first therapeutic to target the genetic cause of this rare disease.